Schedule 13G ownership disclosure

Contineum Therapeutics Inc

Class A Common Stock · CUSIP: 21217B100

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Sectoral Asset Management Inc

    Shares: 800,787.00 · Class: 4.2%

  • Jerome G. Pfund

    Shares: 950,786.00 · Class: 4.99%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-013643
Form type
SCHEDULE 13G/A
Filer
Contineum Therapeutics, Inc.
CIK
CIK 1855175
Filed
Feb 14, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub